376 related articles for article (PubMed ID: 14662401)
1. Storage and voiding symptoms: pathophysiologic aspects.
Andersson KE
Urology; 2003 Nov; 62(5 Suppl 2):3-10. PubMed ID: 14662401
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists.
Price D
Eur Urol; 2001; 40 Suppl 4():5-11. PubMed ID: 11786674
[TBL] [Abstract][Full Text] [Related]
3. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
Andersson KE
Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
[TBL] [Abstract][Full Text] [Related]
4. LUTS treatment: future treatment options.
Andersson KE
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):934-47. PubMed ID: 17696154
[TBL] [Abstract][Full Text] [Related]
5. alpha1-adrenoceptors and bladder function.
Andersson K
Eur Urol; 1999; 36 Suppl 1():96-102. PubMed ID: 10393481
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
7. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
Jhang JF; Liao CH; Kuo HC
Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.
Tubaro A; Carter S; Trucchi A; Punzo G; Petta S; Miano L
Drugs Aging; 2003; 20(3):185-95. PubMed ID: 12578399
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
Andersson KE; Gratzke C
Nat Clin Pract Urol; 2007 Jul; 4(7):368-78. PubMed ID: 17615548
[TBL] [Abstract][Full Text] [Related]
11. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding.
Chen YC; Kuo HC
J Formos Med Assoc; 2014 Mar; 113(3):161-5. PubMed ID: 24630033
[TBL] [Abstract][Full Text] [Related]
12. The significance of abdominal straining in men with lower urinary tract symptoms.
Reynard JM; Peters TJ; Lamond E; Abrams P
Br J Urol; 1995 Feb; 75(2):148-53. PubMed ID: 7531591
[TBL] [Abstract][Full Text] [Related]
13. The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.
Nickel JC
Urology; 2003 Sep; 62(3 Suppl 1):34-41. PubMed ID: 12957198
[TBL] [Abstract][Full Text] [Related]
14. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
Ruggieri MR; Braverman AS; Pontari MA
J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275
[TBL] [Abstract][Full Text] [Related]
15. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
Djavan B
Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology: the varieties of bladder overactivity.
Mostwin JL
Urology; 2002 Nov; 60(5 Suppl 1):22-6; discussion 27. PubMed ID: 12493346
[TBL] [Abstract][Full Text] [Related]
17. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.
Hyman MJ; Groutz A; Blaivas JG
J Urol; 2001 Aug; 166(2):550-2; discussion 553. PubMed ID: 11458066
[TBL] [Abstract][Full Text] [Related]
18. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications.
O'Leary MP
Urology; 2003 Sep; 62(3 Suppl 1):15-23. PubMed ID: 12957196
[TBL] [Abstract][Full Text] [Related]
19. Lower urinary tract symptoms in the older male.
Hsieh K; Taylor JA; Albertsen PC
Conn Med; 2003 Sep; 67(8):487-90. PubMed ID: 14587129
[TBL] [Abstract][Full Text] [Related]
20. Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.
Sironi D; Levorato CA; Deiana G; Borgonovo G; Belussi D; Ranieri A; Lembo A
Arch Ital Urol Androl; 2002 Jun; 74(2):90-4. PubMed ID: 12161944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
